Dr. Fatima Moosa

Fatima Moosa is a South African infectious diseases researcher whose work centers on respiratory pathogens, vaccine effectiveness, and surveillance in high HIV-prevalence settings. Affiliated with national sentinel surveillance platforms, her research integrates clinical, laboratory, and genomic data to inform public health policy and immunization strategies.

Her publications highlight influenza and COVID-19 vaccine effectiveness, risk factors for severe respiratory illness in children and adults, and innovative surveillance approaches such as home-based testing. She has also contributed to cohort studies on community-acquired pneumonia and to genomic and transmission analyses of Bordetella pertussis, demonstrating strength in epidemiologic methods and molecular characterization.

Moosa’s work advances understanding of disease burden, variant-specific severity, and the interaction between HIV, tuberculosis, and respiratory infections. Notable contributions include applying test-negative designs and sentinel surveillance to guide vaccine policy, as well as postmortem and cohort investigations that clarify drivers of mortality and transmission in African contexts.